Article Versions Notes

Mou Y, Wen S, Wang Y, Zhao Y, Li Y-P, Sha H-K, Gui L-J, Jiang Z-Y, Xu X-M. Discovery of Novel Tofacitinib–ADTOH Molecular Hybridization Derivatives for the Treatment of Ulcerative Colitis. Antioxidants. 2025; 14(3):325. https://doi.org/10.3390/antiox14030325

Mou, Yi, Shuai Wen, Yan Wang, Yao Zhao, Ying-Ping Li, Hong-Kai Sha, Li-Juan Gui, Zheng-Yu Jiang, and Xiang-Ming Xu. 2025. "Discovery of Novel Tofacitinib–ADTOH Molecular Hybridization Derivatives for the Treatment of Ulcerative Colitis" Antioxidants 14, no. 3: 325. https://doi.org/10.3390/antiox14030325

Mou, Y., Wen, S., Wang, Y., Zhao, Y., Li, Y.-P., Sha, H.-K., Gui, L.-J., Jiang, Z.-Y., & Xu, X.-M. (2025). Discovery of Novel Tofacitinib–ADTOH Molecular Hybridization Derivatives for the Treatment of Ulcerative Colitis. Antioxidants, 14(3), 325. https://doi.org/10.3390/antiox14030325